Am I eligible for the program?

You may be eligible for our free prescription program if you meet the requirements below:

  • You have been prescribed a Johnson & Johnson operating company donated medication
  • You meet the eligibility income requirements for the medication(s). You may view the income requirements below
  • You don’t have insurance or medicine is not covered
    • Some patients with Medicare Prescription Drug Coverage (Part D) who cannot afford their medicines and who meet certain financial criteria may also be eligible for assistance
      • A report from your pharmacy or an Explanation of Benefits (EOB) statement from your insurer that shows your out-of-pocket costs for the current year can be requested and may be submitted with your application. In order to qualify for the program, you must spend 4% or more of your gross annual income on prescription drugs.
  • You live in the United States or a U.S. Territory
  • You are being treated by a U.S. licensed doctor as an outpatient
Medication
Select Family Size

BALVERSA®
(erdafitinib) Tablets

DARZALEX®
(daratumumab) Injection for intravenous infusion

DARZALEX FASPRO®
(daratumumab and hyaluronidase-fihj), injection for subcutaneous use

EDURANT® 1
(rilpivirine) Tablets

ELMIRON®
(pentosan polysulfate sodium) Capsules

ERLEADA®
(apalutamide) Tablets

HALDOL® Decanoate
(haloperidol) IM Injection Only

IMBRUVICA®
(ibrutinib) Capsules/Tablets

INTELENCE® 1
(etravirine) Tablets

INVEGA HAFYERA™ †
(paliperidone palmitate) Extended-Release Injectable Suspension

INVEGA SUSTENNA® †
(paliperidone palmitate) Extended-Release Injectable Suspension

INVEGA TRINZA®
(paliperidone palmitate) Extended-Release Injectable Suspension

INVOKAMET®† 1
(canagliflozin/metformin HCI) Tablets

INVOKAMET® XR† 1
(canagliflozin/metformin HCI) Tablets

INVOKANA®1
(canagliflozin) Tablets

MONOVISC®
(high molecular weight hyaluronan) Injection

ORTHOVISC®
(high molecular weight hyaluronan) Injection

PONVORY
(ponesimod) Tablets

PREZCOBIX®1
(darunavir 800mg/cobicistat 150mg) Tablets

PREZISTA® 1
(darunavir) Tablets/Oral Suspension

PROCRIT® †
(epoetin alfa) Injection

REMICADE® †
(infliximab) IV Infusion

RISPERDAL CONSTA® †
(risperidone) Long-Acting Injection

RYBREVANT®
(amivantamab-vmjw) Injection

SIMPONI® †
(golimumab) Injection

SIMPONI ARIA®
(golimumab) IV Infusion

SIRTURO® †
(bedaquiline) Tablets

SPORANOX® †
(itraconazole) Capsules

SPORANOX® †
(itraconazole) Oral Solution

SPRAVATO® †
(esketamine) Nasal Spray, for intranasal use, CIII

STELARA®
(ustekinumab) Injection, for subcutaneous or intravenous use

SYMTUZA® †
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets

TREMFYA®
(guselkumab) Injection, for subcutaneous use

XARELTO® † 1
(rivaroxaban) Tablets or Oral Suspension

YONDELIS®
(trabectedin) Injection for intravenous infusion

ZYTIGA®
(abiraterone acetate) Tablets

Call us at 1-800-652-6227 for more information.
Don’t see your medicine listed? Click here for for OPSUMIT®, TRACLEER®, UPTRAVI®, VELETRI®, VENTAVIS®